← Back to Search

Other

transcutaneous electrical nerve stimulation devices for Visual Impairment (PuLCA Trial)

N/A
Waitlist Available
Led By Eric Porges, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Fluent English speaker with reading and writing proficiency.
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1 day
Awards & highlights

PuLCA Trial Summary

This trial will test different ways of stimulating the vagus nerve to see which is best at making the pupil respond.

Eligible Conditions
  • Visual Impairment
  • Eye Disease

PuLCA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

PuLCA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ocular response after transcutaneous nerve stimulation

PuLCA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group A: ExperimentalExperimental Treatment1 Intervention
Within-subjects design with a randomization of the order of tVNS administered parameters
Group II: Group B: Active ComparatorActive Control1 Intervention
Within-subjects design with a randomization of the order of tVNS administered parameters

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,696 Total Patients Enrolled
Eric Porges, PhDPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
80 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who are the ideal candidates to participate in this research?

"Individuals aged between 18 and 30 with a visual disability are suitable to take part in this clinical trial. A maximum of 34 people will be accepted."

Answered by AI

Is enrollment still available for this research endeavor?

"Clinicaltrials.gov confirms that this medical trial, which initially went live on March 1st 2022 and was last updated February 7th 2022, is no longer recruiting patients. However, the same website has identified 53 other clinical trials actively seeking participants at this time."

Answered by AI

Does the age criterion for this trial extend beyond thirty years old?

"The requirements for this trial stipulate that those hoping to participate must be aged between 18 and 30. Separately, there are 20 studies aimed at minors, while 40 trials target adults over 65 years of age."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Pupillometry and Locus Coeruleus Activation (PuLCA)
2023. "Pupillometry and Locus Coeruleus Activation (PuLCA)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04579653.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top